Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Riverstone Holdings Limited (AP4.SI)
Singapore, SG
Riverstone Holdings Limited, an investment holding company, primarily manufactures and distributes gloves for both cleanroom and healthcare applications from its base in Malaysia. Its extensive cleanroom product line encompasses finger cots, static-shielding and packaging bags, face masks, and wipers. The company also offers a wide array of other consumables, including hairnets, antistatic gloves, conductive latex finger cots, static-dissipative footwear (shoes, safety booties, and shoe covers), cleanroom coveralls, ESD rubber bands, sticky mats and rollers, polyester and microfiber swabs, and specialized cleanroom papers. For the healthcare sector, Riverstone provides various medical products, notably nitrile examination gloves in blue, white, black, and accelerator-free options. In addition to its manufacturing activities, the company trades in latex products and distributes cleanroom supplies. These offerings are sold under the RS brand and are utilized across the hard disk drive, semiconductor, and healthcare industries. With a global presence, Riverstone exports its products to Asia, Europe, and the Americas. Founded in 1989, Riverstone Holdings Limited is headquartered in Singapore and operates as a subsidiary of Raffles Nominees (PTE.) Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.78% | +21.09% | +13.38% | +17.11% | +3.49% | +2.30% | +21.09% | +50.85% | -36.88% | +100.00% | +1,030.16% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%-10.7% Q1'26: -14.5% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-26.3% Q1'26: -27.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+22.4% Q1'26: +29.3% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+25.0% ★ Q1'26: +28.9% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+22.3% ★ Q1'26: +23.0% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-0.1% Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
560.19M
est: 573.76M (-2.4%)
|
654.86M
est: 633.74M (+3.3%)
|
817.44M
est: 844.15M (-3.2%)
|
921.03M
est: 922.62M (-0.2%)
|
988.97M
est: 1.00B (-1.2%)
|
1.83B
est: 1.86B (-1.5%)
|
3.08B
est: 3.08B (-0.1%)
|
1.26B
est: 1.28B (-1.5%)
|
914.78M
est: 3.30B (-72.3%)
|
1.07B
est: 1.16B (-7.1%)
|
958.16M
est: 1.02B (-6.2%)
|
1.04B
975.18M – 1.12B
+1.3% YoY
|
1.13B
1.02B – 1.26B
+9.0% YoY
|
1.19B
1.10B – 1.31B
+5.6% YoY
|
| EBITDA |
162.25M
est: 259.15M (-37.4%)
|
159.46M
est: 286.24M (-44.3%)
|
197.08M
est: 381.28M (-48.3%)
|
191.80M
est: 416.72M (-54.0%)
|
206.05M
est: 452.29M (-54.4%)
|
896.45M
est: 839.04M (+6.8%)
|
1.91B
est: 1.39B (+37.4%)
|
479.91M
est: 577.69M (-16.9%)
|
339.81M
est: 1.38B (-75.4%)
|
423.63M
est: 482.85M (-12.3%)
|
308.24M
est: 427.16M (-27.8%)
|
432.79M
407.66M – 467.64M
+1.3% YoY
|
471.95M
425.07M – 524.71M
+9.0% YoY
|
498.18M
458.53M – 546.42M
+5.6% YoY
|
| EBIT |
144.36M
est: 233.53M (-38.2%)
|
138.85M
est: 257.94M (-46.2%)
|
149.64M
est: 343.58M (-56.4%)
|
152.02M
est: 375.52M (-59.5%)
|
158.08M
est: 407.57M (-61.2%)
|
841.71M
est: 756.08M (+11.3%)
|
1.86B
est: 1.26B (+48.1%)
|
417.03M
est: 520.57M (-19.9%)
|
279.38M
est: 1.20B (-76.8%)
|
358.73M
est: 421.32M (-14.9%)
|
239.43M
est: 372.72M (-35.8%)
|
377.63M
355.70M – 408.04M
+1.3% YoY
|
411.81M
370.89M – 457.84M
+9.0% YoY
|
434.69M
400.09M – 476.78M
+5.6% YoY
|
| Net Income |
126.55M
est: 117.19M (+8.0%)
|
120.35M
est: 114.17M (+5.4%)
|
127.61M
est: 137.35M (-7.1%)
|
129.69M
est: 134.73M (-3.7%)
|
130.41M
est: 136.26M (-4.3%)
|
647.25M
est: 564.78M (+14.6%)
|
1.42B
est: 1.43B (-0.8%)
|
314.40M
est: 308.35M (+2.0%)
|
220.38M
est: 944.37M (-76.7%)
|
286.93M
est: 301.28M (-4.8%)
|
200.02M
est: 203.67M (-1.8%)
|
196.32M
178.56M – 214.07M
-3.6% YoY
|
217.74M
188.12M – 247.37M
+10.9% YoY
|
238.83M
197.66M – 280.00M
+9.7% YoY
|
| SGA |
37.85M
est: 23.46M (+61.3%)
|
36.74M
est: 25.91M (+41.8%)
|
39.94M
est: 34.51M (+15.7%)
|
37.68M
est: 37.72M (-0.1%)
|
39.49M
est: 40.94M (-3.5%)
|
56.44M
est: 75.95M (-25.7%)
|
76.97M
est: 126.09M (-39.0%)
|
59.32M
est: 52.29M (+13.4%)
|
46.69M
est: 149.03M (-68.7%)
|
54.15M
est: 52.15M (+3.8%)
|
49.97M
est: 46.13M (+8.3%)
|
46.74M
44.03M – 50.50M
+1.3% YoY
|
50.97M
45.91M – 56.67M
+9.0% YoY
|
53.80M
49.52M – 59.01M
+5.6% YoY
|
| EPS |
0.09
est: 0.08 (+8.0%)
|
0.08
est: 0.08 (+5.4%)
|
0.09
est: 0.09 (-7.1%)
|
0.09
est: 0.09 (-3.7%)
|
0.09
est: 0.09 (-4.3%)
|
0.44
est: 0.38 (+15.5%)
|
0.96
est: 0.96 (-0.4%)
|
0.21
est: 0.21 (+0.9%)
|
0.15
est: 0.64 (-76.5%)
|
0.19
est: 0.20 (-5.5%)
|
0.14
est: 0.14 (+1.0%)
|
0.13
0.12 – 0.14
-4.6% YoY
|
0.15
0.13 – 0.17
+13.5% YoY
|
0.16
0.13 – 0.19
+8.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers MSCI Singapore UCITS ETF 1C O9A.SI | 0.08% | 96.8K | 0.50% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.04% | 276.2K | 0.65% |
| 3 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.04% | 25.6K | 0.74% |
| 4 | Avantis International Small Cap Equity ETF AVDS | 0.03% | 110.2K | 0.30% |
| 5 | iShares International Small-Cap Equity Factor ETF ISCF | 0.02% | 97.0K | 0.24% |
| 6 | Schwab International Small-Cap Equity ETF SCHC | 0.02% | 806.4K | 0.06% |
| 7 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.01% | 25.1K | 0.83% |
| 8 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.01% | 1.51M | 0.40% |
| 9 | Dimensional - International Small Cap ETF DFIS | 0.01% | 629.4K | 0.39% |
| 10 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.38M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Wai Keong Lee | Co-Founder, Chief Operating Officer & Executive Director | 516.0K | male |
| Teek Son Wong | Co-Founder, Executive Chairman & Chief Executive Officer | 187.0K | male |
| Chu Mee Chong | Senior Manager & Alternate Director | 150.0K | female |
| Sabariah Binti Salleh | Senior Quality Assurance Manager & Alternate Director | 132.0K | female |
| Lai Yin Chan | Company Secretary | — | female |
| Sing Poew Lim | Group General Manager | — | male |
| Ah Mooi Gan | Sales and Customer Service Manager | — | female |
| Wang Thing Tan | Chief Financial Officer | — | female |
| Francisco Salas | Managing Director | — | male |
| Keat Leong Lee | Co-Chief Operating Officer & Senior Sales Manager | — | male |
| Khor Kuan Ching | General Manager of Eco Medi Glove Sdn Bhd | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AP4.SI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
